Catalyst
Slingshot members are tracking this event:
PDUFA set to June 30, 2018 for both applications of Binimetinib And Encorafenib in Advanced BRAF-mutant Melanoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARRY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 27, 2018
Occurred Source:
http://investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-announces-fda-approval-braftovitm-encorafenib
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Binimetinib, Encorafenib
